Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
about
Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor modelGlioblastoma cancer stem cells: Biomarker and therapeutic advancesIn vivo models of primary brain tumors: pitfalls and perspectives.Single-molecule decoding of combinatorially modified nucleosomesSingle-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaMotility of glioblastoma cells is driven by netrin-1 induced gain of stemnessEstablishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.Current status of gene therapy for brain tumors.Brain tumor cells in circulation are enriched for mesenchymal gene expressionInsulator dysfunction and oncogene activation in IDH mutant gliomas.Comparative analysis of methods for identifying recurrent copy number alterations in cancer.Riparian ecosystems in human cancers.In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cellsOncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapyTargeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.Emerging insights into the molecular and cellular basis of glioblastoma.Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell LinesActivation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.Analysis of SOX2-Regulated Transcriptome in Glioma Stem CellsImp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression.Biological and clinical implications of cancer stem cells in primary brain tumors.Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastomaComparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-)Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1.Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.
P2860
Q21133610-802E823A-1B49-40F5-9DA9-2027D79B55A1Q26859782-8FA09026-3769-461C-B1F2-3E11674DE258Q26862847-0C0A6141-3B2A-4C44-B5C3-5CEA54150F1BQ28830526-5D09737E-25CA-4F48-9E94-2D62E3028507Q29615604-9B00EB46-632A-43D6-AAD7-7144ECC26A2BQ30834482-FA2038C1-1169-497C-9E34-EB9C60238B97Q33572502-2368DDE9-62BF-44C0-88E1-8E04527FA425Q33677057-713FC185-1DAF-4F68-9656-831AA06D3319Q33804713-09DAADDB-BD96-4306-877F-C5BAB3BD8346Q34047392-54AB97FA-E5D8-49F2-BDD5-CD5BA4962DECQ34102273-C812B8EE-FD3D-414B-AF23-064FE9D3405DQ34318157-70871DB8-5009-48DB-B9C3-AA89DFEDF4F4Q34458631-8FF2C4C6-0425-498A-99F7-6C351DEC8524Q34506441-589F76DF-0185-4DBF-98AE-E6D60DF112BAQ34534035-F732C129-94BA-4EA5-8431-803CA467562BQ34581896-0ADFFA3F-A14C-4BDF-BC0C-BAD20078634EQ35545752-90CEBFF8-D59F-4A02-9C8C-021C824F6081Q35648484-7F8DFD26-1ACF-40E9-91D4-C76687E1983CQ35679830-981A7554-AF80-404E-8E10-E425AB287E19Q35759208-00CC3F16-FEF1-4CFC-A399-512AA736A776Q35794896-B52C4E4B-DEDB-4F33-9F2C-090EE5C5BB24Q35867997-77305609-5B9B-49CA-B63D-0088746CB2F5Q35914897-E1849B57-2129-4E5F-92CB-6CFF014D3939Q35974087-76F1FFDB-AC3A-4053-AAFC-4134BE616688Q36062158-FA7A6D8B-B290-4190-BFC5-95FA63F03744Q36145048-3DB9E115-97BF-4F71-B28A-679E01658A96Q36213711-81674A71-0E2A-447F-B8E0-7F75E0D52B14Q36347256-9344247D-745C-4B98-BC24-F9FF345E386EQ36562573-A6C0999A-3EA2-4B66-A803-F51F6D2CB6B6Q36575238-04A60C94-A6DF-4364-A180-C4A1411EB6BCQ36618220-2778A6D6-B333-4334-9C91-3D8C24BED176Q36636067-2DAA7479-6232-44EF-B311-1583CA8721CFQ36756817-763AE284-2BEC-4204-8DDC-1CC717486358Q36866011-33D7D773-F79E-402D-9EA8-1BBB79B14167Q36879211-29F3DB33-A0F4-4F23-9CC6-D2BB568A08E1Q36917721-3498EE23-8521-41FE-98AD-6528448C1B7BQ36947035-334B0469-E507-456A-AA54-97F68C100068Q37126620-BBD41CEA-1CFC-4114-BA53-716513C6833EQ37230411-89A01DFF-2A22-4D51-B839-EB3C402FD8B3Q37660295-469D2568-4B58-4439-BF4C-496AFF70D0DD
P2860
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
@ast
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
@en
type
label
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
@ast
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
@en
prefLabel
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
@ast
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
@en
P2093
P2860
P356
P1433
P1476
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
@en
P2093
Anat O Stemmer-Rachamimov
Anoop P Patel
David N Louis
Gayatry Mohapatra
Hiroaki Wakimoto
Ryuichi Kanai
Stephen Yip
William T Curry
Zachary R Barnard
P2860
P304
P356
10.1093/NEUONC/NOR195
P577
2011-11-07T00:00:00Z